跳至主要内容
临床试验/NCT01331200
NCT01331200已完成不适用

Early Mobilization of Ischemic Stroke Patients Within 24-hours After Intravenous-tPA Infusion.

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2011年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
20
试验地点
1
主要终点
Level of Patient Disability post-TPA Infusion.

研究概览

简要总结

The purpose of this study is to study the safety and feasibility of mobilization of acute ischemic stroke patients treated with IV-tPA between 12-24 hours of treatment.

详细描述

Abstract:

Introduction

Historical precedence exists demonstrating that early intensive care unit (ICU) mobilization of patients reduces risks of complication and lengths of hospital stay, and may improve long-term health status of patients.

Objective

To determine the safety of early mobilization by physical and/or occupational therapy in acute ischemic stroke patients within 24-hours of IV-tPA infusion and to examine if early mobilization leads to shortened ICU and hospital length of stay.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients post acute ischemic stroke that have been treated with intravenous tissue plasminogen activator (IV-tPA)
  • 13 hours have elapsed since initiation of intravenous TPA infusion
  • Patients are hemodynamically stable (e.g., not on vasopressors or antihypertensive drips or requiring multiple IV PRN boluses of either medication)
  • Patient is able to actively engage in the evaluation

排除标准

  • Patients with femoral sheaths or recent removal of femoral sheaths
  • Patients who are hemodynamically unstable, with active bleeding from lines, catheters, INT site or wounds or angioedema
  • Electrocardiogram showing (HR>100)
  • Vital signs (HR > 100, SBP <90 or >180, DBP <70 or > 105)
  • Patients experiencing marked diaphoresis, facial pallor, intense anxious or painful facial expression (especially in aphasic patients)

结局指标

主要结局

Level of Patient Disability post-TPA Infusion.

时间窗: 30-days post-IV tPA infusion

Study participants will be contacted at approximately 3 to 5-days and 30-days post-IV tPA infusion to capture level of disability by use of Modified Rankin Scale.

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other

研究点 (1)

Loading locations...

相似试验